Prostate Cancer
Conditions
Keywords
prostate cancer advanced or metastatic
Brief summary
In hospitals, the standard prostate cancer announcement system is based on oral and written information. To improve this system, we have developed animated videos that retrace the patient's care path. This is an exploratory, controlled, before-and-after, multicenter study designed to assess the effect of a standard announcement system reinforced by animated videos on patients' level of understanding of prostate cancer diagnosis and treatment. Patients' perception of information will be assessed using the EORTC QLQ-INFO25 questionnaire.
Interventions
OTHERAnimated video
delivery of written and oral information, supported by animated videos.
Sponsors
Direction Centrale du Service de Santé des Armées
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Collection of the patient's non-opposition prior to participation in the study. 2. Patient aged ≥ 18 years at inclusion. 3. Patient with newly diagnosed advanced or metastatic prostate cancer. 4. Patients due to start systemic therapy. 5. Patients undergoing consultation. 6. Patient affiliated to a social security scheme. 7. Patient capable, according to the physician-investigator, of communicating well, understanding and complying with the requirements of the study. 8. Patient with a smartphone or computer to review the video at home.
Exclusion criteria
1. Patient related to any member of the study staff or having a close relationship or conflict of interest with the sponsor. 2. Patient to receive only local treatment. 3. Patient who does not understand French. 4. Clinical follow-up impossible for psychological, family, social or geographical reasons. 5. Vulnerable patient: deprived of liberty by judicial or administrative decision, adult subject to legal protection or unable to express non-opposition.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| EORTC QLQ-INFO25 score | Through study completion (30 days) | overall score of the EORTC QLQ-INFO25 questionnaire at D0 and D30 completed by the patient in each group |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| EORTC QLQ-INFO25 score differences | Through study completion (30 days) | difference in EORTC QLQ-INFO25 global score between D0 and D30 in each group |
Countries
France, Guadeloupe
Contacts
Primary ContactCarole Helissey
Outcome results
None listed